Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases

We present three patients with EB who were prescribed pharmaceutical‐grade sublingually administered CBMs comprising tetrahydrocannabinol and cannabidiol. All three patients reported improved pain scores, reduced pruritus and reduction in overall analgesic drug int ake.

Source: British Journal of Dermatology - November 14, 2018 Category: Dermatology Authors: N.H.B. Schr äder, J.C. Duipmans, B. Molenbuur, A.P. Wolff, M.F. Jonkman Tags: Case Report: Therapy Source Type: research